TKA

World’s First Total Knee Replacement Patient Treated with PolarisAR Breakthrough Mixed-Reality Surgical Guidance System

Retrieved on: 
Monday, March 18, 2024
Technology, Medical Devices, Surgery, Hospitals, FDA, Software, Other Health, General Health, Health, Data Management, Stellar, Knee, TKA, Surgeon, Environment, Hospital, Workflow, Medical device

PolarisAR , a developer of advanced mixed-reality surgical guidance technology, announced the first total knee arthroplasty (TKA) using its STELLAR Knee mixed-reality surgical guidance system.

Key Points: 
  • PolarisAR , a developer of advanced mixed-reality surgical guidance technology, announced the first total knee arthroplasty (TKA) using its STELLAR Knee mixed-reality surgical guidance system.
  • View the full release here: https://www.businesswire.com/news/home/20240318792314/en/
    The world's first total knee arthroplasty (TKA) was performed using the breakthrough STELLAR Knee mixed-reality surgical guidance system from PolarisAR.
  • STELLAR Knee is a mixed-reality surgical navigation platform that guides TKA procedures by displaying measured and computed data overlaid directly in a 3D environment.
  • The STELLAR Knee system is designed to offer precise control over intraoperative variables compared to traditional instruments, navigation systems, and first-generation augmented reality.

New Knee Research Finds Exactech Technologies Improve Patient Outcomes

Retrieved on: 
Wednesday, March 20, 2024
TKA, Patient, Journal, Research, Acquisition, GPS, Motion, MD, Function, Surgeon, Pain, Stanford University, Instability

"Optimizing soft tissue balance is critical to the success of total knee arthroplasty," said James Huddleston, MD, of Stanford University.

Key Points: 
  • "Optimizing soft tissue balance is critical to the success of total knee arthroplasty," said James Huddleston, MD, of Stanford University.
  • "Exactech's ligament-driven technology provides full-range intraoperative balance data, allowing surgeons to create patient-centric plans with consideration for the ever-important mid-flexion stability.
  • The results of this study are powerful in demonstrating the beauty of personalized knee arthroplasty and the importance of addressing instability and improved satisfaction."
  • The results demonstrated that Exactech's ligament-driven knee technology did not significantly increase operative time, and the patients, on average, experienced an eight-hour shorter hospital stay and yielded clinically significant improvements on Knee Society Knee and Function scores.

JOURNAL OF ORTHOPEDICS STUDY REVEALS BENEFIT OF INCREDIWEAR AFTER TOTAL KNEE ARTHROPLASTY

Retrieved on: 
Tuesday, March 12, 2024
Temperature, TKA, Surgeon, Germanium, Patient, TED, Journal, Motion, Overalls, Carbon, Patient satisfaction, Brace, Pain management, Clutch (eggs), Pain, PTS, Surgery, Swelling, PubMed, Medical device

CHICO, Calif., March 12, 2024 /PRNewswire/ -- The Journal of Orthopedics published the results of a study concluding that Incrediwear, the leading provider of innovative therapeutic wear, provides more benefit after total knee arthroplasty (TKA) than compression stockings or Thrombo-Embolsim Deterrent (TED) Hose, routinely prescribed after TKA. The study, "Noncompressive sleeves versus compression stockings after total knee arthroplasty: A prospective pilot study," aimed to compare the efficacy of non-compressive sleeves versus compression stockings for postoperative recovery in TKA patients.

Key Points: 
  • CHICO, Calif., March 12, 2024 /PRNewswire/ -- The Journal of Orthopedics published the results of a study concluding that Incrediwear , the leading provider of innovative therapeutic wear, provides more benefit after total knee arthroplasty (TKA) than compression stockings or Thrombo-Embolsim Deterrent (TED) Hose, routinely prescribed after TKA.
  • The study, "Noncompressive sleeves versus compression stockings after total knee arthroplasty: A prospective pilot study," aimed to compare the efficacy of non-compressive sleeves versus compression stockings for postoperative recovery in TKA patients.
  • The prospective pilot study involved a sample size of 55 TKA patients assigned to either the non-compressive Incrediwear sleeve group or the compression stocking group.
  • To be recognized by the prestigious Journal of Orthopedics further reinforces that medical professionals should be using Incrediwear for anyone undergoing total knee arthroplasty."

Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting  

Retrieved on: 
Monday, February 12, 2024
TKA, AI, MD, Patient satisfaction, Pain, Surgeon, 3D modeling, UKA, Risk, Deformity, THA, Associate, Patient, Duke University, SNN, Movement, AAOS, American Academy, Medical device

Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024.

Key Points: 
  • Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024.
  • Delivering solutions for differing patient types coupled with planning and execution tools is essential to personalizing surgery.
  • “Smith+Nephew’s technology platform is the only one in the market that allows for personalized planning using simulation and AI.
  • When introducing personalized options to manage specific pathologies, we see increased patient satisfaction and clinical outcomes.

THINK Surgical and LINK Forge Strategic Collaboration for Robotic TKA

Retrieved on: 
Monday, February 12, 2024
TKA, LINK, THINK, FDA, ID, Surgeon, Database, Health, Patient, Partnership, Medical device

Through this collaboration, THINK Surgical will add the LinkSymphoKnee System to THINK Surgical's ID-HUB™, a proprietary data bank of implant modules for use with its TMINI™ Miniature Robotic System.

Key Points: 
  • Through this collaboration, THINK Surgical will add the LinkSymphoKnee System to THINK Surgical's ID-HUB™, a proprietary data bank of implant modules for use with its TMINI™ Miniature Robotic System.
  • THINK Surgical is committed to providing open platform orthopedic surgical robots that support implants from multiple manufactures.
  • The collaboration between LINK and THINK Surgical aligns with LINK's commitment to offering the most innovative solutions to the market.
  • The integration of THINK Surgical's advanced robotic technology with LINK's state-of-the-art TKA system, LinkSymphoKnee, further enhances patient care."

Research Finds Robotic Assistance in Cementless Total Knee Arthroplasty Does Not Improve Revision Rates Two Years Following Surgery

Retrieved on: 
Monday, February 12, 2024
SAN, Hospital, TKA, Infection, Odds ratio, Risk, Medicare, Patient, AAOS, Ageing, Failure, Research, American Academy

SAN FRANCISCO, Feb. 12, 2024 /PRNewswire/ -- As the use of robotic assistance in total knee arthroplasty (TKA) has grown, there has been limited research looking at whether it improved the risk of revision.

Key Points: 
  • SAN FRANCISCO, Feb. 12, 2024 /PRNewswire/ -- As the use of robotic assistance in total knee arthroplasty (TKA) has grown, there has been limited research looking at whether it improved the risk of revision.
  • New data showed that revision rates were similar in conventional and robotic-assisted cementless TKA at two years post-operatively.
  • The primary and secondary outcomes were two-year all-cause odds of revision between cementless TKA with or without robotic assistance and two-year odds of the specific indication for revision surgery.
  • A total of 9,220 cementless TKAs were identified, with 4,120 (45%) performed with robotic assistance.

Allay Therapeutics Announces Development and Commercialization Agreement with Maruishi Pharmaceutical for Ultra-Sustained Pain Therapeutics in Japan

Retrieved on: 
Monday, December 18, 2023
Biotechnology, Surgery, Health, Pharmaceutical, Health Technology, Quality of life, Pain management, ATX, Perioperative, Pain, LLP, Therapy, Opioid, TKA, Patient, Cooley LLP

Allay Therapeutics, Inc. (Allay) today announced that they have entered into a license agreement with Maruishi Pharmaceutical Co., Ltd. (Maruishi), providing Maruishi with exclusive rights to develop and commercialize Allay’s lead investigational drug candidate, ATX101, and other ultra-sustained analgesic implantable drug candidates for acute pain in Japan.

Key Points: 
  • Allay Therapeutics, Inc. (Allay) today announced that they have entered into a license agreement with Maruishi Pharmaceutical Co., Ltd. (Maruishi), providing Maruishi with exclusive rights to develop and commercialize Allay’s lead investigational drug candidate, ATX101, and other ultra-sustained analgesic implantable drug candidates for acute pain in Japan.
  • Allay retains the right to develop and commercialize ATX101 in all territories outside of Japan.
  • "Maruishi is one of the leading specialty pharmaceutical companies in perioperative care and anesthetic settings, with strong development and commercial capabilities within the acute post-operative pain management arena,” said Adam Gridley, Chief Executive Officer of Allay.
  • "We’re especially excited to partner with Maruishi given their similar mission to improve quality of life and ease post-surgical recovery.

New SPR Therapeutics Data Presented at ASRA Pain Medicine Meeting 2023

Retrieved on: 
Monday, November 13, 2023
Twilight anesthesia, Spondylosis, ASRA, Safety, TKA, Chronic pain, End, Bandage, Therapy, Adhesive, Spine, SPR, Patient, Cohort (statistics), PNS, Pain management, Joint, Pain, Diagnosis, Randomized controlled trial, Medicare, Society, Skin, Quality of life, Neuropathic pain, SPRINT, Dentistry, Treatment

CLEVELAND, Nov. 13, 2023 (GLOBE NEWSWIRE) -- At the 22nd Annual American Society of Regional Anesthesia (ASRA) Pain Medicine Meeting in New Orleans, three posters on the SPRINT® PNS System were shared for the first time.

Key Points: 
  • CLEVELAND, Nov. 13, 2023 (GLOBE NEWSWIRE) -- At the 22nd Annual American Society of Regional Anesthesia (ASRA) Pain Medicine Meeting in New Orleans, three posters on the SPRINT® PNS System were shared for the first time.
  • The first poster, “Percutaneous PNS Relieves Persistent Postoperative Pain and Improves Function after TKA: Results from a Placebo-Controlled Randomized Controlled Trial” was recognized with a President’s Choice Award from ASRA.
  • This poster highlights the results from a prospective trial evaluating the impact of SPRINT peripheral nerve stimulation (PNS) used for chronic knee pain after total knee arthroplasty (TKA) surgery.
  • The SPRINT PNS treatment group (n=18) demonstrated a 47 percent improvement in walking ability measured by a six-minute walk test whereas the placebo group (n=20) demonstrated a nine percent decrease.

American Joint Replacement Registry Releases 10th Annual Report

Retrieved on: 
Friday, November 3, 2023
American Joint Replacement Registry, MSTR, III, Publication, Medicare, American Association of Neurological Surgeons, Nursing, Abdominal ultrasonography, Registry, Fracture, Orthopedic surgery, Paced Auditory Serial Addition Test, Estate (law), KOOS, ASR, TKA, Hip, Growth, Database, SER, COVID-19, Surgeon, AANS, American Academy, Hospital, Annual report, Collection, THA, Shoulder, Patient, Robotics, AAOS, FTR, Medical device, Pharmaceutical industry, BBC, MD

ROSEMONT, Ill., Nov. 3, 2023 /PRNewswire/ -- The American Joint Replacement Registry (AJRR), the cornerstone of the American Academy of Orthopaedic Surgeons (AAOS) Registry Program, published its 2023 Annual Report on hip and knee arthroplasty procedural trends and patient outcomes today. Marking the 10th anniversary edition of the report, the data represents over 3.1 million primary and revision hip and knee arthroplasty procedures performed between 2012 and 2022. This is a 23% growth in procedural cases from the prior report.

Key Points: 
  • ROSEMONT, Ill., Nov. 3, 2023 /PRNewswire/ -- The American Joint Replacement Registry (AJRR), the cornerstone of the American Academy of Orthopaedic Surgeons (AAOS) Registry Program , published its 2023 Annual Report on hip and knee arthroplasty procedural trends and patient outcomes today.
  • Marking the 10th anniversary edition of the report, the data represents over 3.1 million primary and revision hip and knee arthroplasty procedures performed between 2012 and 2022.
  • The American Joint Replacement Registry (AJRR) , the Academy's hip and knee replacement registry, is the cornerstone of the AAOS's Registry Program, and the world's largest national registry of hip and knee joint replacement data by annual procedural count, with more than 3 million procedures contained within its database.
  • Additional registries include the Fracture & Trauma Registry (FTR), the Musculoskeletal Tumor Registry (MsTR), the Shoulder & Elbow Registry (SER), and the American Spine Registry (ASR), a collaborative effort between the American Association of Neurological Surgeons (AANS) and the AAOS.

Ganymed Robotics Announces Appointment of Seasoned Leadership Team to Bring to Market Its Next Generation Surgical Technology

Retrieved on: 
Tuesday, October 3, 2023
Biotechnology, Technology, Other Health, Health, Biometrics, Robotics, Health Technology, Other Technology, Medical Devices, Software, Surgery, EOS, General counsel, Marketing, Person, Operating, TKA, Ganymed, Executive Committee, Popular Executive Committee of Valencia, EOS imaging, Elective surgery, Management, BAE Systems Electronic Systems

Former companies include ZimmerBiomet, Alphatec, EOS Imaging, Corwave, Beckton Dickinson, Robocath, Médecins Sans Frontières.

Key Points: 
  • Former companies include ZimmerBiomet, Alphatec, EOS Imaging, Corwave, Beckton Dickinson, Robocath, Médecins Sans Frontières.
  • The company aims to secure and standardize a complex surgical gesture, so that each patient gets the right, personalized care.
  • It has developed a proprietary technology platform built around two disruptive innovations: contactless localization of the bones and human-machine collaborative movement.
  • With the arrival of high-profile senior executives on its leadership team, Ganymed is ideally positioned to successfully accelerate the execution of its strategic, industrial, and operational development plan.